Behov for større sikkerhed omkring medicin til børn og unge i Danmark

Anne-Cathrine Finnemann Viuff, Lene Bistrup, Pernille Mathiesen, Mia Ortved Bjerager, Tine Brink Henriksen

Abstract

Only 30% of medication used for children and adolescents and 10% of the medication used for neonates has been evaluated for use in these populations. Infants and children differ from adults regarding pharmacodynamic and -kinetics, but they also differ from each other due to e.g. age, weight, and body composition, as we argue in this review. There is only limited knowledge within this area leading to the use of off-label, extemporaneous and unlicensed medication. Greater national vigilance in medication for children and adolescent is warranted to secure better and safer medicine for newborns, infants, children and adolescents.

Bidragets oversatte titelGreater vigilance in medication for children and adolescent is warranted in Denmark
OriginalsprogDansk
ArtikelnummerV01200003
TidsskriftUgeskrift for Laeger
Vol/bind182
Udgave nummer45
ISSN0041-5782
StatusUdgivet - 2 nov. 2020

Fingeraftryk

Dyk ned i forskningsemnerne om 'Behov for større sikkerhed omkring medicin til børn og unge i Danmark'. Sammen danner de et unikt fingeraftryk.

Citationsformater